Total Funding
16
48
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
172993
mimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine.
- Marc Thurner: Chief Executive OfficerPast Role: RegenHU, Founder & Chief Executive Officer
- Tiziano Serra: Founder & CSO
About the Company
mimiX Biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. mimiX Biotherapeutics will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue
equivalents for regenerative, personalized, and precision medicine.
